Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Aggression × Ifosfamide × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 54 Lymphoma, Large B-Cell, Diffuse 49 Lymphoma, Non-Hodgkin 28 Hodgkin Disease 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Burkitt Lymphoma 21 Lymphoma, Follicular 16 Leukemia 14 Lymphoma, Large-Cell, Immunoblastic 13 Lymphoma, Mantle-Cell 12 Lymphoma, Large-Cell, Anaplastic 11 Lymphoma, B-Cell, Marginal Zone 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Recurrence 9 Lymphoma, B-Cell 8 Immunoblastic Lymphadenopathy 5 Dendritic Cell Sarcoma, Interdigitating 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, T-Cell, Peripheral 4 Waldenstrom Macroglobulinemia 3 Neoplasms 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myeloid, Acute 3 Immunoproliferative Disorders 3 Blast Crisis 3 Neoplasms, Plasma Cell 2 Mycosis Fungoides 2 Multiple Myeloma 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2

Interventions

selinexor 1 pegfilgrastim 1 midostaurin 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡